Catalent Pharma Solutions has completed the acquisition of the clinical trial supplies business of Aptuit.
Subscribe to our email newsletter
The acquisition is expected to expand Catalent’s development & clinical services business and enhance its position in development solutions and advanced delivery technologies for drugs, biologics, and consumer health products.
Catalent’s development & clinical services business offers clinical supply solutions, analytical services for both small and large molecule drugs, inhaled and sterile product development, and regulatory consulting.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.